Uptick in respiratory illnesses across the U.S.
Watch CBS News
Be the first to know
Get browser notifications for breaking news, live events, and exclusive reporting.
Similar Posts
Google is rolling out new AI models for health care. Here’s how doctors are using them
Sundar Pichai, CEO of Google and Alphabet, speaks on artificial intelligence during a Bruegel think tank conference in Brussels, Belgium, on Jan. 20, 2020. Yves Herman | Reuters Google on Wednesday announced MedLM, a suite of new health-care-specific artificial intelligence models designed to help clinicians and researchers carry out complex studies, summarize doctor-patient interactions and…
Therapists Say These 6 Common Habits Are Fueling Your Anxiety
Anxiety is a very normal but a very unwelcome feeling. Most of us would choose not to experience it if we could. In some ways, it’s like a smoke alarm, said Natasha Reynolds, a psychotherapist at Bloom Psychology & Wellness in Toronto. That smoke detector alerts you to actual danger and allows you to get…
‘Cancer found in pregnancy has robbed me of seeing my baby grow’
There are concerns signs of cancer in pregnant women are being dismissed as pregnancy symptoms.
Lilly to build $2.5 billion Germany plant as obesity drug demand soars | Reuters News Agency
DealsHealth 17 November 2023, 11:31 am 1 minute Reuters exclusively reported that Eli Lilly (LLY.N) will build its first plant in Germany in the western town of Alzey for 2.3 billion euros ($2.5 billion), the U.S. drugmaker said on Friday, as the sector scrambles to meet soaring demand for new diabetes and obesity therapies. Market…
The weight loss drug boom isn’t over yet — here’s what to expect in the year ahead
George Frey | Bloomberg | Getty Images Weight loss drugs exploded into the public eye this year, and 2024 will bring more change to the evolving market. The drugs skyrocketed in popularity in 2023 as they helped patients shed significant weight, despite hefty price tags, mixed insurance coverage and a handful of unpleasant side effects. …
MoonLake Immunotherapeutics explores sale | Reuters News Agency
Business & FinanceDealsHealth 14 July 2023, 5:43 pm 1 minute MoonLake Immunotherapeutics (MLTX.O), a developer of an antibody-derived treatment for inflammatory skin conditions, is working with an investment bank and having early-stage conversations with drugmakers interested in a potential acquisition. Market Impact MoonLake’s shares ended trading up 8.4% at $54.27 on the news on Friday,…
